|Articles|February 12, 2015

Biotec Services International Completes its Rebrand into PCI

Author(s)Applied Clinical Trials Editorial Staff

PCI is pleased to announce that further to the acquisition in September 2014 of Biotec Services International, the company has rebranded as part of the PCI group.

PCI is pleased to announce that further to the acquisition in September 2014 of Biotec Services International, the company has rebranded as part of the PCI group. This rebrand expands PCI’s capability to deliver an integrated pharmaceutical service for global studies of investigational medicinal products and include manufacturing, packaging and labeling, QP and GMP consultancy, global distribution and returned drug management, as well as consultant services.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related to this article

October 17th, 2026

2026 SCRS Global Site Solutions Summit: Should the Industry Rethink What Scale Means?

Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: The Difference Between Owning a Group of Sites and Operating Them as One Integrated Platform

Paradigm’s Kurt Mussina touches on why he rejects the “site management organization” model in favor of one unified business.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?

ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Causes Technology Adoption to Stall?

ProofPilot’s Lauren Briggs touches on why site tech adoption hinges on the first 90 days after rollout, and why tools succeed only when they remove work from a site’s plate rather than adding another login to juggle.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What's the Biggest Policy Gap Delaying Integrated, Community-Based Research Being the Norm?

Jennifer Byrne, CEO, Javara touches on why fixing clinical research requires sustained infrastructure investment and workforce development.

Dan White, CEO, and Dr. Tom Kreamer, CMO

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Should Sponsors and CROs Change About How They Contract with a Network?

Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized partnerto speed startup timelines and strengthen execution.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Does it Take to Turn Three Independent Site Organizations into One Functioning Network?

Sequoia Clinical Research’s CEO Dan White and CMO, Dr. Tom Kreamer explain what it takes to merge three site organizations into one network.

October 17th, 2026

2026 SCRS Global Site Solutions Summit: What Does Embedding Research into Existing Physician Practices Require?

Javara CEO Jennifer Byrne talks about the requirements for embedding clinical trials directly into physician practices and why solving the “last mile” of trial participation means building infrastructure at the actual point of care.